1. Letts JA, Sazanov LA (2017). Clarifying the supercomplex: the higher-order organization of the mitochondrial electron transport chain. Nat Struct Mol Biol 24(10):800-808.
2. Liu X, Kim CN, Yang J, Jemmerson R, Wang X (1996). Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86(1):147-157.
3. DiMauro S, Schon EA (2008). Mitochondrial disorders in the nervous system. Annu Rev Neurosci 31:91-123.
4. Gehmlich K, Dodd MS, Allwood JW, Kelly M, Bellahcene M, Lad HV et al (2015). Changes in the cardiac metabolome caused by perhexiline treatment in a mouse model of hypertrophic cardiomyopathy. Mol Biosyst 11(2):564-573.
5. Drummond GR, Selemidis S, Griendling KK, Sobey CG (2011). Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov 10(6):453-471.
6. Bota DA, Davies KJ (2002). Lon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism. Nat Cell Biol 4(9):674-680.
7. Venkatesh S, Lee J, Singh K, Lee I, Suzuki CK (2012). Multitasking in the mitochondrion by the ATP-dependent Lon protease. Biochim Biophys Acta 1823(1):56-66.
8. Lu B, Lee J, Nie X, Li M, Morozov YI, Venkatesh S et al (2013). Phosphorylation of human TFAM in mitochondria impairs DNA binding and promotes degradation by the AAA+ Lon protease. Molecular cell 49(1):121-132.
9. Ondrovicova G, Liu T, Singh K, Tian B, Li H, Gakh O et al (2005). Cleavage site selection within a folded substrate by the ATP-dependent lon protease. J Biol Chem 280(26):25103-25110.
10. Granot Z, Kobiler O, Melamed-Book N, Eimerl S, Bahat A, Lu B et al (2007). Turnover of mitochondrial steroidogenic acute regulatory (StAR) protein by Lon protease: the unexpected effect of proteasome inhibitors. Mol Endocrinol 21(9):2164-2177.
11. Tian Q, Li T, Hou W, Zheng J, Schrum LW, Bonkovsky HL (2011). Lon peptidase 1 (LONP1)-dependent breakdown of mitochondrial 5-aminolevulinic acid synthase protein by heme in human liver cells. J Biol Chem 286(30):26424-26430.
12. Kil IS, Ryu KW, Lee SK, Kim JY, Chu SY, Kim JH et al (2015). Circadian Oscillation of Sulfiredoxin in the Mitochondria. Mol Cell 59(4):651-663.
13. Crewe C, Schafer C, Lee I, Kinter M, Szweda LI (2017). Regulation of Pyruvate Dehydrogenase Kinase 4 in the Heart through Degradation by the Lon Protease in Response to Mitochondrial Substrate Availability. J Biol Chem 292(1):305-312.
14. Kuo CY, Chiu YC, Lee AY, Hwang TL (2015). Mitochondrial Lon protease controls ROS-dependent apoptosis in cardiomyocyte under hypoxia. Mitochondrion 23:7-16.
15. Bernstein SH, Venkatesh S, Li M, Lee J, Lu B, Hilchey SP et al (2012). The mitochondrial ATP-dependent Lon protease: a novel target in lymphoma death mediated by the synthetic triterpenoid CDDO and its derivatives. Blood 119(14):3321-3329.
16. Nie X, Li M, Lu B, Zhang Y, Lan L, Chen L et al (2013). Down-regulating overexpressed human Lon in cervical cancer suppresses cell proliferation and bioenergetics. PLoS One 8(11):e81084.
17. Liu Y, Lan L, Huang K, Wang R, Xu C, Shi Y et al (2014). Inhibition of Lon blocks cell proliferation, enhances chemosensitivity by promoting apoptosis and decreases cellular bioenergetics of bladder cancer: potential roles of Lon as a prognostic marker and therapeutic target in baldder cancer. Oncotarget 5(22):11209-11224.
18. Di K, Lomeli N, Wood SD, Vanderwal CD, Bota DA (2016). Mitochondrial Lon is over-expressed in high-grade gliomas, and mediates hypoxic adaptation: potential role of Lon as a therapeutic target in glioma. Oncotarget 7(47):77457-77467.
19. Luo B, Wang M, Hou N, Hu X, Jia G, Qin X et al (2016). ATP-Dependent Lon Protease Contributes to Helicobacter pylori-Induced Gastric Carcinogenesis. Neoplasia 18(4):242-252.
20. Quiros PM, Espanol Y, Acin-Perez R, Rodriguez F, Barcena C, Watanabe K et al (2014). ATP-dependent Lon protease controls tumor bioenergetics by reprogramming mitochondrial activity. Cell Rep 8(2):542-856.
21. Hansen J, Corydon TJ, Palmfeldt J, Durr A, Fontaine B, Nielsen MN et al (2008). Decreased expression of the mitochondrial matrix proteases Lon and ClpP in cells from a patient with hereditary spastic paraplegia (SPG13). Neuroscience 153(2):474-482.
22. Felk S, Ohrt S, Kussmaul L, Storch A, Gillardon F (2010). Activation of the mitochondrial protein quality control system and actin cytoskeletal alterations in cells harbouring the MELAS mitochondrial DNA mutation. J Neurol Sci 295(1-2):46-52.
23. Pinti M, Gibellini L, Guaraldi G, Orlando G, Gant TW, Morselli E et al (2010). Upregulation of nuclear-encoded mitochondrial LON protease in HAART-treated HIV-positive patients with lipodystrophy: implications for the pathogenesis of the disease. AIDS 24(6):841-850.
24. Strauss KA, Jinks RN, Puffenberger EG, Venkatesh S, Singh K, Cheng I et al (2015). CODAS syndrome is associated with mutations of LONP1, encoding mitochondrial AAA+ Lon protease. Am J Hum Genet 96(1):121-135.
25. Bezawork-Geleta A, Saiyed T, Dougan DA, Truscott KN (2014). Mitochondrial matrix proteostasis is linked to hereditary paraganglioma: LON-mediated turnover of the human flavinylation factor SDH5 is regulated by its interaction with SDHA. FASEB J 28(4):1794-1804.
26. Dikoglu E, Alfaiz A, Gorna M, Bertola D, Chae JH, Cho TJ et al (2015). Mutations in LONP1, a mitochondrial matrix protease, cause CODAS syndrome. Am J Med Genet A 167(7):1501-1509.
27. Wu SB, Ma YS, Wu YT, Chen YC, Wei YH (2010). Mitochondrial DNA mutation-elicited oxidative stress, oxidative damage, and altered gene expression in cultured cells of patients with MERRF syndrome. Mol Neurobiol 41(2-3):256-266.
28. Hoshino A, Okawa Y, Ariyoshi M, Kaimoto S, Uchihashi M, Fukai K et al (2014). Oxidative post-translational modifications develop LONP1 dysfunction in pressure overload heart failure. Circ Heart Fail 7(3):500-509.
29. Venkatesh S, Li M, Saito T, Tong M, Rashed E, Mareedu S et al (2019). Mitochondrial LonP1 protects cardiomyocytes from ischemia/reperfusion injury in vivo. J Mol Cell Cardiol 128:38-50.
30. Yoneda T, Benedetti C, Urano F, Clark SG, Harding HP, Ron D (2004). Compartment-specific perturbation of protein handling activates genes encoding mitochondrial chaperones. J Cell Sci 117(Pt 18):4055-4066.
31. Zhao Q, Wang J, Levichkin IV, Stasinopoulos S, Ryan MT, Hoogenraad NJ (2002). A mitochondrial specific stress response in mammalian cells. EMBO J 21(17):4411-4419.
32. Lin YF, Haynes CM (2016). Metabolism and the UPR(mt). Mol Cell 61(5):677-682.
33. Nargund AM, Pellegrino MW, Fiorese CJ, Baker BM, Haynes CM (2012). Mitochondrial import efficiency of ATFS-1 regulates mitochondrial UPR activation. Science 337(6094):587-590.
34. Vannuvel K, Renard P, Raes M, Arnould T (2013). Functional and morphological impact of ER stress on mitochondria. J Cell Physiol 228(9):1802-1818.
35. Spinazzi M, Casarin A, Pertegato V, Salviati L, Angelini C (2012). Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells. Nat Protoc 7(6):1235-1246.
36. Wittig I, Braun HP, Schagger H (2006). Blue native PAGE. Nat Protoc 1(1):418-428.
37. Wai T, Garcia-Prieto J, Baker MJ, Merkwirth C, Benit P, Rustin P et al (2015). Imbalanced OPA1 processing and mitochondrial fragmentation cause heart failure in mice. Science 350(6265):aad0116.
38. Marin-Garcia J, Akhmedov AT (2016). Mitochondrial dynamics and cell death in heart failure. Heart Fail Rev 21(2):123-336.
39. Chen Y, Liu Y, Dorn GW, 2nd (2011). Mitochondrial fusion is essential for organelle function and cardiac homeostasis. Circ Res 109(12):1327-31.
40. Papanicolaou KN, Kikuchi R, Ngoh GA, Coughlan KA, Dominguez I, Stanley WC et al (2012). Mitofusins 1 and 2 are essential for postnatal metabolic remodeling in heart. Circ Res 111(8):1012-1026.
41. Tezze C, Romanello V, Desbats MA, Fadini GP, Albiero M, Favaro G et al (2017). Age-Associated Loss of OPA1 in Muscle Impacts Muscle Mass, Metabolic Homeostasis, Systemic Inflammation, and Epithelial Senescence. Cell Metab 25(6):1374-89.e6.
42. Anand R, Wai T, Baker MJ, Kladt N, Schauss AC, Rugarli E et al (2014). The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission. J Cell Biol 204(6):919-929.
43. Tyynismaa H, Carroll CJ, Raimundo N, Ahola-Erkkila S, Wenz T, Ruhanen H et al (2010). Mitochondrial myopathy induces a starvation-like response. Hum Mol Genet 19(20):3948-3958.
44. Lee MS (2015). Effect of mitochondrial stress on systemic metabolism. Ann N Y Acad Sci 1350:61-65.
45. Mendez-Lucas A, Hyrossova P, Novellasdemunt L, Vinals F, Perales JC (2014). Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) is a pro-survival, endoplasmic reticulum (ER) stress response gene involved in tumor cell adaptation to nutrient availability. J Biol Chem 289(32):22090-22102.
46. Pinti M, Gibellini L, Liu Y, Xu S, Lu B, Cossarizza A (2015). Mitochondrial Lon protease at the crossroads of oxidative stress, ageing and cancer. Cell Mol Life Sci 72(24):4807-4824.
47. Liu T, Lu B, Lee I, Ondrovicova G, Kutejova E, Suzuki CK (2004). DNA and RNA binding by the mitochondrial lon protease is regulated by nucleotide and protein substrate. J Biol Chem 279(14):13902-13910.
48. Zurita Rendon O, Shoubridge EA (2018). LONP1 Is Required for Maturation of a Subset of Mitochondrial Proteins, and Its Loss Elicits an Integrated Stress Response. Mol Cell Biol 38(20):e00412-17.
49. Song M, Franco A, Fleischer JA, Zhang L, Dorn GW, 2nd (2017). Abrogating Mitochondrial Dynamics in Mouse Hearts Accelerates Mitochondrial Senescence. Cell Metab 26(6):872-83.e5.
50. Chen H, Vermulst M, Wang YE, Chomyn A, Prolla TA, McCaffery JM et al (2010). Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations. Cell 141(2):280-289.
51. Nakada K, Sato A, Hayashi J (2009). Mitochondrial functional complementation in mitochondrial DNA-based diseases. Int J Biochem Cell Biol 41(10):1907-1913.
52. Smirnova E, Shurland DL, Ryazantsev SN, van der Bliek AM (1998). A human dynamin-related protein controls the distribution of mitochondria. J Cell Biol 143(2):351-358.
53. Ishihara N, Fujita Y, Oka T, Mihara K (2006). Regulation of mitochondrial morphology through proteolytic cleavage of OPA1. EMBO J 25(13):2966-2977.
54. Bota DA, Davies KJ (2016). Mitochondrial Lon protease in human disease and aging: Including an etiologic classification of Lon-related diseases and disorders. Free Radic Biol Med 100:188-198.
55. Vincent EE, Sergushichev A, Griss T, Gingras MC, Samborska B, Ntimbane T et al (2015). Mitochondrial Phosphoenolpyruvate Carboxykinase Regulates Metabolic Adaptation and Enables Glucose-Independent Tumor Growth. Mol Cell 60(2):195-207.
56. Stark R, Pasquel F, Turcu A, Pongratz RL, Roden M, Cline GW et al (2009). Phosphoenolpyruvate cycling via mitochondrial phosphoenolpyruvate carboxykinase links anaplerosis and mitochondrial GTP with insulin secretion. J Biol Chem 284(39):26578-26590.
57. Wang S, Chen XA, Hu J, Jiang JK, Li Y, Chan-Salis KY et al (2015). ATF4 Gene Network Mediates Cellular Response to the Anticancer PAD Inhibitor YW3-56 in Triple-Negative Breast Cancer Cells. Mol Cancer Ther 14(4):877-888.